P2 purinergic receptors on osteoblasts and osteoclasts: potential targets for drug development

SJ Dixon, SM Sims - Drug Development Research, 2000 - Wiley Online Library
Extracellular nucleotides like ATP bind to cell surface receptors (P2 purinergic receptors) in
many tissues. P2X receptor subtypes are intrinsic ion channels that mediate depolarization …
被引用次数：97 相关文章

P2 Purinergic Receptors on Osteoblasts and Osteoclasts: Potential Targets for Drug Development

SJ Dixon, SM Sims - Drug Development Research, 2000 - ir.lib.uwo.ca
Extracellular nucleotides like ATP bind to cell surface receptors (P2 purinergic receptors) in
many tissues. P2X receptor subtypes are intrinsic ion channels that mediate depolarization …

P2 purinergic receptors on osteoblasts and osteoclasts: Potential targets for drug development

SJ Dixon, SM Sims - Drug Development Research, 2000 - Wiley Online Library
Extracellular nucleotides like ATP bind to cell surface receptors (P2 purinergic receptors) in
many tissues. P2X receptor subtypes are intrinsic ion channels that mediate depolarization …

[引用][C] P2 purinergic receptors on osteoblasts and osteoclasts: Potential targets for drug development

SJ DIXON, SM SIMS - Drug development research, 2000 - pascal-francis.inist.fr
P2 purinergic receptors on osteoblasts and osteoclasts : Potential targets for drug development
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …

[引用][C] P2 purinergic receptors on osteoblasts and osteoclasts: Potential targets for drug development

D SJ - Drug Development Res., 2000 - cir.nii.ac.jp

[引用][C] P2 purinergic receptors on osteoblasts and osteoclasts: Potential targets for drug development

SJ Dixon, SM Sims - Drug Development Research, 2000 - cir.nii.ac.jp
P2 purinergic receptors on osteoblasts and osteoclasts: Potential targets for drug
development | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

[引用][C] P2 purinergic receptors on osteoblasts and osteoclasts: Potential targets for drug development

SJ DIXON, SM SIMS - Drug development research, 2000 - Wiley-Liss